Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 6/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.35 |
| ▸ | RAD52 | P43351 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3118931 | 0.98 | ALDH1A1 (0.56) | ALDH1A1SOAT1TSHRNAAACYP3A4 | |
| SCHEMBL2900732 | 0.91 | ALDH1A1 (0.59) | ALDH1A1SOAT1TSHRNAAAEPHX1 | |
| SCHEMBL6940068 | 0.89 | ALDH1A1 (0.68) | ALDH1A1SOAT1TSHRNAAACYP3A4 | |
| SCHEMBL23093044 | 0.89 | TSHR (0.46) | ALDH1A1TSHRNAAACYP3A4EPHX1 | |
| SCHEMBL9111420 | 0.88 | TSHR (0.46) | ALDH1A1TSHRNAAACYP3A4EPHX1 | |
| SCHEMBL10344245 | 0.87 | ALDH1A1 (0.72) | ALDH1A1SOAT1TSHRNAAAEPHX1 | |
| SCHEMBL9839017 | 0.85 | ALDH1A1 (0.52) | ALDH1A1TSHRNAAACYP3A4EPHX1 | |
| SCHEMBL4848050 | 0.83 | NAAA (0.55) | ALDH1A1TSHRNAAAEPHX1ACHE | |
| SCHEMBL4852353 | 0.83 | NAAA (0.55) | ALDH1A1TSHRNAAAEPHX1ACHE | |
| SCHEMBL4855892 | 0.83 | NAAA (0.55) | ALDH1A1TSHRNAAAEPHX1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2303840-A2 | CALCIUM ION CHANNEL MODULATORS&USES THEREOF | Lectus Therapeutics Limited (GB) | 2011-04-06 | — | — | EP | disclosed |
| WO-2010001179-A2 | CALCIUM ION CHANNEL MODULATORS & USES THEREOF | LECTUS THERAPEUTICS LIMITED (GB) | 2010-01-07 | — | — | WO | disclosed |
| WO-2009136965-A1 | COMPOSITIONS AND METHODS COMPRISING CAPURAMYCIN ANALOGUES | SEQUELLA, INC. (US) | 2009-11-12 | — | — | WO | disclosed |
| EP-1898951-A1 | PHARMACEUTICAL PREPARATION CONTAINING AN ANGIOTENSIN II RECEPTOR ANTAGONIST AND A CALCIUM CHANNEL BLOCKER | Daiichi Sankyo Company, Limited (JP) | 2008-03-19 | — | — | EP | disclosed |
| EP-1865964-A1 | TOPICAL FORMULATIONS FOR USE IN THE TREATMENT OR PREVENTION OF DERMATOLOGICAL CONDITIONS | Stegram Pharmaceuticals Limited (GB) | 2007-12-19 | — | — | EP | disclosed |
| WO-2007001067-A2 | SOLID DOSAGE FORM COMPRISING AN ANGIOTENSIN II RECEPTOR ANTAGONIST AND A CALCIUM CHANNEL BLOCKER | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2007-01-04 | — | — | WO | disclosed |
| WO-2007001065-A2 | METHOD FOR THE PREPARATION OF A WET GRANULATED DRUG PRODUCT | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2007-01-04 | — | — | WO | disclosed |
| WO-2007001066-A1 | PHARMACEUTICAL PREPARATION CONTAINING AN ANGIOTENSIN II RECEPTOR ANTAGONIST AND A CALCIUM CHANNEL BLOCKER | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2007-01-04 | — | — | WO | disclosed |
| WO-2006054119-A1 | TOPICAL FORMULATIONS FOR USE IN THE TREATMENT OR PREVENTION OF DERMATOLOGICAL CONDITIONS | STEGRAM PHARMACEUTICALS LTD (GB) | 2006-05-26 | — | — | WO | disclosed |
| EP-1377577-A1 | PYRROLE DERIVATES FOR TREATING CYTOKINE MEDIATED DISEASES | Sankyo Company Limited (JP) | 2004-01-07 | — | — | EP | disclosed |
| WO-2002057264-A1 | PYRROLE DERIVATES FOR TREATING CYTOKINE MEDIATED DISEASES | SANKYO COMPANY LIMITED (JP) | 2002-07-25 | — | — | WO | disclosed |
| WO-2001002413-A1 | BAFIlOMYCIN DERIVATIVES WITH ANTICANCER ACTIVITY | INSTITUTO BIOMAR S.A. (ES) | 2001-01-11 | — | — | WO | disclosed |
| US-5073551-A | Antibiotics | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1991-12-17 | — | — | US | disclosed |
| EP-0335390-A2 | Novel cephalosporin compounds | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1989-10-04 | — | — | EP | disclosed |
| US-4496562-A | 7-Substituted-3-cephem-4-carboxylic acid esters | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1985-01-29 | — | — | US | disclosed |